Last synced on 21 February 2025 at 11:05 pm

Hybrid Stent Graft, Thoracic Aortic Lesion Treatment

Page Type
Product Code
Definition
Repair or replacement of damaged or diseased vessel of the aortic arch and descending thoracic aorta, with or without involvement of ascending aorta, using vascular grafts and/or stent grafts placed during open surgical repair.
Physical State
Combination of vascular grafts and/or stent grafts
Technical Method
An open surgical procedure in which a vascular graft and/or stent graft is placed inside the thoracic aorta, redirecting blood flow away from the lesion and replacing or relining the aortic wall.
Target Area
Ascending Aorta, Aortic Arch and Descending Thoracic Aorta
Review Panel
Cardiovascular
Submission Type
PMA
Device Classification
Class 3
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
Yes
Life-Sustain/Support Device
Yes
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code QSK to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.

Hybrid Stent Graft, Thoracic Aortic Lesion Treatment

Page Type
Product Code
Definition
Repair or replacement of damaged or diseased vessel of the aortic arch and descending thoracic aorta, with or without involvement of ascending aorta, using vascular grafts and/or stent grafts placed during open surgical repair.
Physical State
Combination of vascular grafts and/or stent grafts
Technical Method
An open surgical procedure in which a vascular graft and/or stent graft is placed inside the thoracic aorta, redirecting blood flow away from the lesion and replacing or relining the aortic wall.
Target Area
Ascending Aorta, Aortic Arch and Descending Thoracic Aorta
Review Panel
Cardiovascular
Submission Type
PMA
Device Classification
Class 3
GMP Exempt?
No
Summary Malfunction Reporting
Ineligible
Implanted Device
Yes
Life-Sustain/Support Device
Yes
Third Party Review
Not Third Party Eligible

No Linked CFR Text

The FDA has not linked product code QSK to any particular section of the CFR (Code of Federal Regulations). There are multiple reasons why this might be the case:

  • The product code was created for a class III submission that does not follow the normal PMN or PMA path - e.g., for a device that falls under HDE (Humanitarian Device Exemption) or EUA (Emergency Use Authorization).
  • The FDA has generated the product code for an existing Class III device, as a result of a PMA supplement that modifies the device in a way that it can't fit under the existing product code originally assigned
  • The product code was created for internal use at the FDA, and not for classification or regulatory-related purposes.